Crossmark

Silodosin 8 mg improves benign prostatic obstruction in Caucasian patients with lower urinary tract symptoms suggestive of benign prostatic enlargement: results from an explorative clinical study

Crossref DOI link: https://doi.org/10.1186/s12894-018-0326-7

Published Online: 2018-03-05

Published Print: 2018-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Fusco, Ferdinando https://orcid.org/0000-0002-9509-8906
Creta, Massimiliano

Longo, Nicola

Persico, Francesco

Franco, Marco

Mirone, Vincenzo
Funding

Funding for this research was provided by:

Recordati S.p.A. (Sponsor study code: KMD 3213 IT-CL 0477)
More Information

Article History

Received: 3 December 2017

Accepted: 22 February 2018

First Online: 5 March 2018

Ethics approval and consent to participate

: The study protocol was approved by the Institutional Review Board of the University of Naples Federico II (Institutional review board approval No.143/15). All patients gave their written informed consent to participate in the study.

: Informed consent was obtained from the patients for publication of this study.

: Ferdinando Fusco, Massimiliano Creta and Vincenzo Mirone have been consultants for Recordati S.p.A.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Document is current

Any future updates will be listed below